NCT03957278View on ClinicalTrials.gov

A Study to Evaluate the DAISe System During Neurointervention for Acute Ischemic Stroke

NATerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

August 15, 2019

Primary Completion Date

May 1, 2020

Study Completion Date

November 9, 2021

Conditions
Stroke, Acute
Interventions
DEVICE

DAISe System

The DAISe System is indicated for revascularization of patients with acute ischemic stroke for the removal of fresh thrombi from vessels in the neurovasculature.

Trial Locations (2)

140

Hospital Civil Marie Curie, Charleroi

1070

Erasme Hospital, Brussels

Sponsors
All Listed Sponsors
lead

MIVI Neuroscience, Inc.

INDUSTRY

NCT03957278 - A Study to Evaluate the DAISe System During Neurointervention for Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter